(Q47914456)

6 February 2018

title

Cell-mediated and humoral immune reactions to human tumours (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

5 March 2023

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790710

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

5 March 2023

author name string

R. W. Baldwin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790710

5 March 2023

M. J. Embleton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790710

5 March 2023

J. S. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790710

5 March 2023

M. J. Langman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790710

5 March 2023

language of work or name

English

0 references

publication date

1 July 1973

1 reference

6 February 2018

15 July 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4790710

full work available at URL

5 March 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910120108

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910120108

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

International Journal of Cancer

5 March 2023

published in

1 reference

6 February 2018

volume

12

1 reference

6 February 2018

page(s)

73-83

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions

cites work

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status

5 March 2023

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes

5 March 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Embryonic antigen expression in chemically induced rat hepatomas and sarcomas.

5 March 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen

5 March 2023

6

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Immune response to urinary bladder tumours in man

5 March 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular and humoral immune responses to human urinary bladder carcinomas

5 March 2023

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cytotoxic lymphocytes in melanoma patients

5 March 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular immunity to human breast carcinoma

5 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular and humoral immunity against human malignant melanoma

5 March 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Studies on cellular immunity and its serum-mediated inhibition in moloney-virus-induced mouse sarcomas

5 March 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium

5 March 2023

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Demonstration of cell-mediated immunity to human neoplasms of various histological types

5 March 2023

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

5 March 2023

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Autoimmunization with irradiated tumour cells in human malignant melanoma

5 March 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

5 March 2023

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Immunological reactivity in patients with carcinoma of colon.

5 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Specific immune response in human skin carcinoma.

5 March 2023

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation

5 March 2023

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

5 March 2023

25

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

A microassay for cell-mediated immunity

5 March 2023

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910120108

5 March 2023

Identifiers

1 reference

6 February 2018

1 reference

6 February 2018